FIELD: medicine. SUBSTANCE: for assessment of levamisole sensitivity there are screened the patients whose levels of regenerated E-rosetting cells in peripheral blood are of 37.5 % or less, and/or levamisole medication leads to decreasing the above value less than 4 % and increasing the activity of autoresponsive and phytohemagglutinin- induced T-suppressor cells not less than 6 and 5.5 %, respectively. Thereafter, such patients are tested for activity of tuberculin/histamine-induced T-suppressor cells, and normal suppression index is estimated according to the formula given in the description of the invention. EFFECT: increased information content. 6 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DETERMINING INDIVIDUAL SENSITIVITY OF PATIENTS WITH RHEUMATOID ARTHRITIS TO TREATMENT WITH LEVAMISOL | 0 |
|
SU1550422A1 |
METHOD OF DETERMINING INDIVIDUAL SENSITIVITY TO LEVAMISOL IN RHEUMATOID ARTHRITIS CASES | 0 |
|
SU1455318A1 |
METHOD FOR TREATING SECONDARY IMMUNODEFICIENCY | 1994 |
|
RU2099051C1 |
METHOD OF DETERMINING PROLIFERATIVE ACTIVITY OF LYMPHOCYTES IN RHEUMATOID ARTHRITIS | 0 |
|
SU1422156A1 |
METHOD OF EVALUATION OF B-LYMPHOCYTE PROLIFERATIVE ACTIVITY IN VITRO USING BIOFLAVANOID FROM THE ROSE ROOT | 1992 |
|
RU2088932C1 |
IMMUNOMODULATING AGENT | 1993 |
|
RU2108100C1 |
METHOD FOR CARRYING OUT COMPLEX THERAPY OF INFECTIOUS TOXIC CHRONIC ADNEXITIS OF NONSPECIFIC ETIOLOGY | 1996 |
|
RU2145891C1 |
IMMUNOMODULATING DRUG | 1988 |
|
RU2027434C1 |
METHOD OF DETERMINING THYMUS ACTIVITY | 0 |
|
SU1470056A1 |
METHOD FOR PRODUCTION OF POLYCLONAL T-CELL VACCINE USEFUL IN TREATMENT OF IMMUNOLOGICAL DISORDERS | 2004 |
|
RU2277422C2 |
Authors
Dates
1994-06-15—Published
1986-08-04—Filed